Brainsway share price today

(BWAY)

Brainsway share price is $9.35 & ₹796.60 as on 25 Dec 2024, 2.30 'hrs' IST

$9.35

▲

0.2

(2.19%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Brainsway share price in Dollar and Rupees. Guide to invest in Brainsway from India. Also see the sentimental analysis on Indian investors investing in Brainsway. Get details on the Indian mutual funds that are investing in Brainsway. Get Analyst recommendations and forecasts along with all the Brainsway's financials.

Brainsway share price movements

Today's Low: $9.22
Today's High: $9.47
$9.35
1.39%
Downside
Day's Volatility :2.64%
Upside
1.27%
52 Weeks Low: $4.61
52 Weeks High: $10.98
$9.35
50.7%
Downside
52 Weeks Volatility :58.01%
Upside
14.85%

Brainsway Returns

Period	Brainsway Ltd	Index (Russel 2000)
3 Months	13.89%	0.0%
6 Months	55.32%	0.0%
1 Year	43.63%	0.0%
3 Years	20.03%	-21.1%

Brainsway Key Statistics

in dollars & INR

Previous Close	$9.15
Open	$9.37
Today's High	$9.47
Today's Low	$9.22
Market Capitalization	$175.9M
Today's Volume	$39.5K
52 Week High	$10.98
52 Week Low	$4.61
Revenue TTM	$36.4M
EBITDA	$1.8M
Earnings Per Share (EPS)	$0.08
PE Ratio	116.88
Profit Margin	1.67%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	1.44%

How to invest in Brainsway from India?

It is very easy for Indian residents to invest directly in Brainsway from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Brainsway stock in both Indian Rupees (INR) and US Dollars (USD). Search for Brainsway or BWAY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Brainsway or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Brainsway shares which would translate to 0.091 fractional shares of Brainsway as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Brainsway, in just a few clicks!

Returns in Brainsway for Indian investors in Rupees

Investment Value

₹1,00,000

Brainsway investment value today

Current value as on today

₹1,45,864

Returns

₹45,864

(+45.86%)

Returns from Brainsway Stock

₹43,625 (+43.63%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Brainsway

-6%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Brainsway on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -6% less investors are searching Brainsway in the last 30 days versus the previous period.

Global Institutional Holdings in Brainsway

Masters Capital Management LLC
4.79%
Renaissance Technologies Corp
1.92%
Essex Investment Management Company, LLC
1.85%
Dafna Capital Management LLC
1.34%
Phoenix Financial Ltd
1.28%
Cresset Asset Management, LLC
0.84%

Analyst Recommendation on Brainsway

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Brainsway(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Brainsway

What analysts predicted

Upside of 46.79%

Current:

$9.35

Target:

$13.73

Insights on Brainsway

Price Movement
In the last 6 months, BWAY stock has moved up by 50.1%
Increasing Revenue
Revenue is up for the last 9 quarters, 5.16M → 10.50M (in $), with an average increase of 8.4% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, 111.0K → 662.0K (in $), with an average increase of 45.4% per quarter
BWAY vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 62.7% return, outperforming this stock by 18.4%
BWAY vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 113.2% return, outperforming this stock by 88.7%
Price to Sales
ForBWAY every $1 of sales, investors are willing to pay $4.3, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Brainsway Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$16.4M	↑ 47.12%
Net Income	$-6.5M	↓ 8.15%
Net Profit Margin	-39.51%	↑ 23.78%

	FY19	Y/Y Change
Revenue	$23.1M	↑ 40.89%
Net Income	$-10.3M	↑ 59.41%
Net Profit Margin	-44.71%	↓ 5.2%

	FY20	Y/Y Change
Revenue	$22.1M	↓ 4.52%
Net Income	$-5.4M	↓ 47.86%
Net Profit Margin	-24.41%	↑ 20.3%

	FY21	Y/Y Change
Revenue	$29.7M	↑ 34.46%
Net Income	$-6.5M	↑ 20.0%
Net Profit Margin	-21.79%	↑ 2.62%

	FY22	Y/Y Change
Revenue	$27.2M	↓ 8.36%
Net Income	$-13.3M	↑ 106.58%
Net Profit Margin	-49.12%	↓ 27.33%

	FY23	Y/Y Change
Revenue	$31.8M	↑ 16.96%
Net Income	$-4.2M	↓ 68.56%
Net Profit Margin	-13.2%	↑ 35.92%

	Q2 FY23	Q/Q Change
Revenue	$7.8M	↑ 18.17%
Net Income	$-1.7M	↓ 31.59%
Net Profit Margin	-21.24%	↑ 15.45%

	Q3 FY23	Q/Q Change
Revenue	$8.3M	↑ 6.04%
Net Income	$-230.0K	↓ 86.17%
Net Profit Margin	-2.77%	↑ 18.47%

	Q4 FY23	Q/Q Change
Revenue	$9.0M	↑ 8.76%
Net Income	$127.0K	↓ 155.22%
Net Profit Margin	1.41%	↑ 4.18%

	Q1 FY24	Q/Q Change
Revenue	$9.1M	↑ 0.73%
Net Income	$111.0K	↓ 12.6%
Net Profit Margin	1.22%	↓ 0.19%

	Q2 FY24	Q/Q Change
Revenue	$10.0M	↑ 10.01%
Net Income	$600.0K	↑ 440.54%
Net Profit Margin	6.0%	↑ 4.78%

	Q3 FY24	Q/Q Change
Revenue	$10.5M	↑ 4.97%
Net Income	$662.0K	↑ 10.33%
Net Profit Margin	6.3%	↑ 0.3%

	FY18	Y/Y Change
Profit	$12.8M	↑ 49.8%

	FY19	Y/Y Change
Profit	$18.0M	↑ 40.32%

	FY20	Y/Y Change
Profit	$17.0M	↓ 5.41%

	FY21	Y/Y Change
Profit	$23.1M	↑ 35.64%

	FY22	Y/Y Change
Profit	$20.0M	↓ 13.05%

	FY23	Y/Y Change
Profit	$23.5M	↑ 17.1%

	Q2 FY23	Q/Q Change
Profit	$5.7M	↑ 18.64%

	Q3 FY23	Q/Q Change
Profit	$6.2M	↑ 7.62%

	Q4 FY23	Q/Q Change
Profit	$6.7M	↑ 9.2%

	Q1 FY24	Q/Q Change
Profit	$6.8M	↑ 1.08%

	Q2 FY24	Q/Q Change
Profit	$7.5M	↑ 10.64%

	Q3 FY24	Q/Q Change
Profit	$7.7M	↑ 2.44%

	FY18	Y/Y Change
Operating Cash Flow	$-3.8M	↑ 8.83%
Investing Cash Flow	$-1.1M	↓ 53.65%
Financing Cash Flow	$-265.0K	↓ 102.39%

	FY19	Y/Y Change
Operating Cash Flow	$-7.2M	↑ 92.0%
Investing Cash Flow	$-2.4M	↑ 115.32%
Financing Cash Flow	$22.5M	↓ 8580.75%

	FY20	Y/Y Change
Operating Cash Flow	$-1.4M	↓ 80.18%
Investing Cash Flow	$-2.5M	↑ 0.78%
Financing Cash Flow	$-1.0M	↓ 104.58%

	FY21	Y/Y Change
Operating Cash Flow	$884.0K	↓ 161.56%
Investing Cash Flow	$-42.2M	↑ 1612.62%
Financing Cash Flow	$41.5M	↓ 4130.68%

	FY22	Y/Y Change
Operating Cash Flow	$-9.8M	↓ 1203.96%
Investing Cash Flow	$42.2M	↓ 199.89%
Financing Cash Flow	$-1.5M	↓ 103.72%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$995.0K	↓ 128.1%
Investing Cash Flow	$-1.5M	↓ 2460.94%
Financing Cash Flow	$-377.0K	↑ 471.21%

Brainsway Technicals Summary

Sell

Neutral

Buy

Brainsway is currently in a neutral trading position according to technical analysis indicators.

Brainsway Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Brainsway Ltd	-3.71%	55.32%	43.63%	20.03%	-4.1%
Stryker Corporation	-4.86%	8.88%	24.0%	37.11%	77.64%
Boston Scientific Corp.	0.95%	18.27%	62.57%	111.2%	102.42%
Edwards Lifesciences Corp.	5.35%	-19.24%	-1.09%	-42.27%	-2.7%
Abbott Laboratories	-2.71%	9.66%	4.53%	-18.87%	32.21%
Medtronic Plc	-4.83%	2.79%	-1.07%	-21.92%	-27.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Brainsway Ltd	116.88	116.88	NA	0.06	0.01	0.01	NA	1.25
Stryker Corporation	39.7	39.7	2.56	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	75.26	75.26	1.65	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	29.1	29.1	6.92	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.88	34.88	2.22	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.94	24.94	1.49	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Brainsway Ltd	Buy	$175.9M	-4.1%	116.88	1.67%
Stryker Corporation	Buy	$141.3B	77.64%	39.7	16.34%
Boston Scientific Corp.	Buy	$134.2B	102.42%	75.26	11.26%
Edwards Lifesciences Corp.	Buy	$44.5B	-2.7%	29.1	65.86%
Abbott Laboratories	Buy	$199.0B	32.21%	34.88	13.99%
Medtronic Plc	Buy	$104.6B	-27.8%	24.94	12.06%

About Brainsway

brainsway is a leading global neurmodulation company with headquarters in jerusalem and the us. our patented breakthrough technology has already treated over 10,000 patients, and has helped usher in a new era in brain disorder treatment. a non-invasive, yet highly effective solution for brain disorders, brainsway has helped thousands of patients across the world, from the unites states to europe to south america, and has the potential to make a difference in the well-being and health of millions of patients worldwide. brainsway's technology offers a much needed alternative for millions of patients from a bleak cycle of insufficiently effective treatments and unpleasant side effects. brainsway's treatment has fda approval for treating patients with major depressive disorder*. the technology is safe, with no systemic or long-term side effects, in addition to being highly convenient, requiring only brief daily sessions over a few weeks. in addition to being used to treat depression daily

Organization	Brainsway
Employees	134
CEO	Mr. Hadar Levy
Industry	Medical Specialties

Management People of Brainsway

Name	Title
Mr. Hadar Levy	Chief Executive Officer
Mr. Avner Hagai	Founder & Director
Prof. Abraham Zangen	Co-Founder, Member of Scientific Advisory Board & Director
Dr. Yiftach Roth Ph.D.	Founder & Chief Scientific Officer
Mr. Ido Marom	Chief Financial Officer
Mr. Gilead Moiseyev	Chief Technology Officer
Mr. Menachem C. Klein Esq.	VP, General Counsel & Corporate Secretary
Mr. Ross Mitchell	Vice President of Global Marketing
Ms. Hillegonda Groen	Vice President of International Sales
Dr. Richard A. Bermudes M.D.	Chief Medical Officer

Important FAQs about investing in Brainsway from India :

What is Brainsway share price today?

Brainsway share price today stands at $9.35, Open: $9.37 ; Previous Close: $9.15 ; High: $9.47 ; Low: $9.22 ; 52 Week High: $10.98 ; 52 Week Low: $4.61. The stock opens at $9.37, after a previous close of $9.15. The stock reached a daily high of $9.47 and a low of $9.22, with a 52-week high of $10.98 and a 52-week low of $4.61.

Can Indians buy Brainsway shares?

Yes, Indians can invest in the Brainsway (BWAY) from India.

With INDmoney, you can buy Brainsway at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Brainsway at zero transaction cost.

How can I buy Brainsway shares from India?

It is very easy to buy Brainsway from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Brainsway be purchased?

Yes, you can buy fractional shares of Brainsway with INDmoney app.

What are the documents required to start investing in Brainsway stocks?

To start investing in Brainsway, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.